or Try an Advanced Search...

    Stage Specialty Pharmaceutical Stocks List

    Symbol Grade Name % Change
    ACRS B Aclaris Therapeutics, Inc. 5.94
    CPRX C Catalyst Pharmaceutical Partners, Inc. -0.12
    TNXP D Tonix Pharmaceuticals Holding Corp. 2.47
    SLGL F Sol-Gel Technologies Ltd. 17.14
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Health Sciences Pharmaceutical Disorders Medication Pharmaceutical Sciences Topical Medication Chemical Substances Common Warts Dermatology Drug Products Drugs Epilepsy Fibromyalgia Headache Hydrogen Hydrogen Peroxide Keratosis Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Stage Specialty Pharmaceutical stocks.

    Symbol Grade Name Weight
    IBRN C iShares Neuroscience and Healthcare ETF 3.97
    FBT D First Trust Amex Biotech Index Fund 3.62
    PBE D PowerShares Dynamic Biotech & Genome 3.0
    PTH D Invesco DWA Healthcare Momentum ETF 2.43
    MNTL D Tema Neuroscience and Mental Health ETF 2.22
    View all Stage Specialty Pharmaceutical ETFs...
    Compare ETFs
    Compare IBRN to MNTL Compare IBRN to PBE Compare PBE to PTH

        Stage Specialty Pharmaceutical Stocks Recent News

        Date Stock Title
        Nov 20 ACRS Aclaris upgraded to overweight by Cantor on in-licensing deal
        Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
        Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
        Nov 19 ACRS Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
        Nov 19 ACRS Aclaris stock soars for second day on licensing deal, analyst upgrades
        Nov 19 ACRS Aclaris Therapeutics secures global rights to Biosion’s antibodies
        Nov 19 ACRS ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
        Nov 18 ACRS Aclaris stock rallies 53% amid licensing deal, Piper upgrade
        Nov 18 TNXP Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
        Nov 18 ACRS Aclaris signs license deal for biologics assets
        Nov 18 ACRS Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
        Nov 18 ACRS Aclaris Therapeutics Announces $80 Million Private Placement
        Nov 18 ACRS Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
        Nov 18 TNXP Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
        Nov 17 SLGL Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 SLGL Sol-Gel Technologies GAAP EPS of -$0.01 beats by $0.04, revenue of $5.36M beats by $1.16M
        Nov 15 CPRX Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
        Nov 15 SLGL Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
        Nov 15 SLGL Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Health Sciences Pharmaceutical Disorders Medication Pharmaceutical Sciences Topical Medication Chemical Substances Common Warts Dermatology Drug Products Drugs Epilepsy Fibromyalgia Headache Hydrogen Hydrogen Peroxide Keratosis Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Medicine
        Stage Specialty Pharmaceutical

        Stage Specialty Pharmaceuticals is a specialty pharmaceutical company that focuses on developing and commercializing innovative treatments for rare and complex diseases. The company works with leading healthcare providers, payers, and patient advocacy groups to develop and deliver treatments that improve the lives of patients. Stage Specialty Pharmaceuticals is committed to providing access to treatments that are safe, effective, and affordable.

        Browse All Tags